Hong Kong Pharmaceuticals & Biotech Stocks

WuXi Biologics (Cayman) Inc., an investment holding company, operates as an open-access technology platform company that provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the People’s Republic of China and internationally.

Hansoh Pharmaceutical Group Company Limited engages in the research and development, manufacture, marketing, and sale of pharmaceuticals and active pharmaceutical ingredients.

Sino Biopharmaceutical Limited, together with its subsidiaries, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

CSPC Pharmaceutical Group Limited, an investment holding company, manufactures and sells pharmaceutical products in the People’s Republic of China, other Asian regions, the Americas, Europe, and internationally.

Innovent Biologics, Inc. operates as a biopharmaceutical company in China.

CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Shanghai Junshi Biosciences Co., Ltd., a bio-pharmaceutical company, engages in the discovery, development, and commercialization of various drugs in the therapeutic areas of oncology, metabolic, auto-immunity, and neurologic diseases in the People’s Republic of China.

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited researches, develops, manufactures, and sells Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and chemical raw material intermediates in the People’s Republic of China and internationally.

RemeGen Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologics for the treatment of autoimmune, oncology, and ophthalmic diseases with unmet medical needs in the People’s Republic of China and internationally.

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in the People’s Republic of China.

Shanghai Henlius Biotech, Inc., a biopharmaceutical company, engages in the research and development of biologics with a focus on oncology and autoimmune diseases worldwide.

China Grand Pharmaceutical and Healthcare Holdings Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and nutrition products, and pharmaceutical raw materials.

Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life sciences research products and services in North America, Europe, China, Japan, the other Asia Pacific regions, and internationally.

Simcere Pharmaceutical Group Limited engages in the research, development, manufacture, and distribution of pharmaceutical and vaccine products for pharmaceutical distributors and government in China.

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products to hospital and medical institutions in the People’s Republic of China.

Akeso, Inc., a clinical-stage biopharmaceutical company, engages in discovery, development and commercialization of therapies.

3SBio Inc. develops, manufactures, markets, and sells biopharmaceuticals in the People’s Republic of China.

Shanghai Haohai Biological Technology Co., Ltd.

Everest Medicines Limited, a clinical-stage biopharmaceutical company, focuses on licensing, developing, and commercializing therapies for addressing critical unmet medical needs in Greater China and other Asia Pacific markets.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd., together with its subsidiaries, researches, develops, manufactures, and sells bio-pharmaceutical products.

China Traditional Chinese Medicine Holdings Co.

SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

Luye Pharma Group Ltd. develops, produces, markets, and sells pharmaceutical products worldwide.

Alphamab Oncology, a clinical-stage biopharmaceutical company, focuses on the research and development, manufacture, and commercialization of oncology biologics.